Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 4

Interventions

Gemcitabine 153Fluorouracil 45Capecitabine 45130-nm albumin-bound paclitaxel 43Oxaliplatin 42Albumin-Bound Paclitaxel 39Leucovorin 31Erlotinib Hydrochloride 30pembrolizumab 23Radiotherapy 22Irinotecan 22Radiosurgery 20Bevacizumab 19Docetaxel 17Cyclophosphamide 17Taxes 13Cisplatin 13Cetuximab 13folfirinox 12Nivolumab 11Surgical Procedures, Operative 7Paclitaxel 7Ipilimumab 7dehydroftorafur 6Standard of Care 6Radiation 6Magnetic Resonance Spectroscopy 6spartalizumab 5ruxolitinib 5durvalumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Pancreatic Neoplasms × Pancreaticoduodenectomy × Clear all
NCT02517268 2025-04-30

WARP

Thomas Jefferson University

Phase NA Completed
98 enrolled 13 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02243358 2023-10-27

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Henry Ford Health System

Phase 2 Completed
24 enrolled 5 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01240304 2019-12-10

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

University of Arkansas

Phase 2 Terminated
10 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00766636 2016-05-19

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡